Vaknin Rachel 4
4 · Microbot Medical Inc. · Filed Aug 3, 2023
Insider Transaction Report
Form 4
Vaknin Rachel
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-01+17,500→ 17,500 totalExercise: $2.43Exp: 2033-08-01→ Common Stock, par value $0.01 per share (17,500 underlying)
Footnotes (1)
- [F1]The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on February 1, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.